Observational studyBMC cardiovascular disorders2026
Association between admission serum phosphate levels and prognosis in post-cardiac arrest patients: a retrospective observational study.
Observational study in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundDespite advances in resuscitation, mortality remains high after cardiac arrest (CA). While serum phosphate is linked to outcomes in critically ill patients, its prognostic value specifically in post-CA populations remains unclear. This study investigated the association between admission serum phosphate levels and 90-day mortality in CA patients.
methodsWe conducted a retrospective cohort study using the MIMIC-IV database (2008–2019), including adult CA patients admitted to the ICU. The primary outcome was 90-day all-cause mortality. Multivariable Cox proportional hazards models adjusted for potential confounders were used to estimate hazard ratios (HRs). Kaplan–Meier curves and restricted cubic spline (RCS) models were employed to assess survival differences and nonlinear dose–response relationships.
resultsA total of 1,079 adult patients with CA were included (median age: 67 years; 61.9% male). Compared with survivors, non-survivors were older, had higher severity scores (SOFA, CCI), and exhibited significant disturbances in multi-organ function markers, including elevated serum phosphate, creatinine, liver enzymes, and coagulation parameters (all P < 0.05). Notably, non-survivors exhibited significantly shorter ICU and hospital lengths of stay, likely reflecting higher early mortality rates. Kaplan–Meier analysis showed distinct survival curves across phosphate quartiles (P < 0.001). In the fully adjusted Cox model, the highest phosphate quartile (Q4 ≥ 5.21 mg/dL) was independently associated with a 45% increased risk of 90-day mortality compared to the lowest quartile (HR = 1.450, 95% CI: 1.098–1.915, P = 0.009). Restricted cubic spline (RCS) analysis revealed that while the unadjusted association was J-shaped, multivariable adjustment uncovered a linear positive correlation, with mortality risk significantly increasing when admission phosphate levels exceeded 4.0 mg/dL.
conclusionsElevated admission serum phosphate is an independent predictor of 90-day mortality in post-CA patients. Beyond traditional markers, it offers complementary prognostic value, supporting early risk stratification and potentially guiding individualized management strategies in this critically ill population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.